Announcement on Authorizing the Chairman of the Company to Use Its Own Funds for Entrusted Financial Management
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 Number: Pro 2019-012
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Authorizing the Chairman of the Company to Use Its Own Funds to Entrust Financial Management
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .
Important Content Reminder:
● Entrusted Wealth Management Amount: Authorizes the Chairman of the Board to exercise the decision-making power of entrusted wealth management not exceeding RMB billion, within which funds can be used on a rolling basis, however, the total entrusted financial balance of surviving at any point in time shall not exceed 5 .4 billion yuan.
● Entrusted Wealth Management Investment Type: Select varieties with high security, good liquidity and low risk to carry out entrusted wealth management business.
● Entrusted financial management period: the period of each investment business shall not exceed 12 months.
1. overview
(I) basic situation
1 , principle: take "standard operation, risk prevention, prudent investment, value preservation and appreciation" as the principle.
2 , Varieties: Select varieties with high security, good liquidity and low risk to carry out entrusted wealth management business.
3 . Funds: own funds.
4 , authorized amount and term: the chairman of the board of directors is authorized to exercise the decision-making power of entrusted financial management not exceeding RMB 5 .3 billion yuan. within the amount, the funds can be used on a rolling basis, but the total balance of entrusted financial management existing at any time point shall not exceed RMB 5 .5 billion yuan. The term of each entrusted financial management shall not exceed 12 months. The authorization period shall be valid for 3 years from the date of approval by the Board of Directors of the Company. The specific investment activities are organized and implemented by the Company's Finance Department.
5 , Implementation Method: Authorize the chairman of the board to decide on matters related to entrusted financial investment within the above amount, including but not limited to: selecting qualified professional financial institutions, selecting specific types of entrusted financial products, specifying the amount and term of entrusted financial management, signing relevant contracts and agreements, etc.
(II) the approval procedures to be performed within the company
2019 , Zhejiang Jianfeng Group Co., Ltd. held the 106 meeting of the 10th board of directors, of which eight directors attended the meeting in person, director Du Zihong entrusted Director Jiang Xiaomeng to attend the meeting and vote on on his behalf. complies with the relevant provisions of the "Company Law" and the company's "Articles of Association", and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, with 9 votes in favor, 0 votes against, and 0 abstentions, the "Proposal on Authorizing the Chairman of the Company to Use Its Own Funds for Entrusted Financial Management " was deliberated and passed.
2. Main Contents
(I) Entrusted Funds Source: Own Funds .
Impact of (II) on the Company
1 . The entrusted financial management of the Company is implemented on the premise of ensuring the daily operation and capital safety of the Company, and does not affect the daily capital turnover of the Company or the normal development of the Company's business.
2 . Through moderate and low-risk financial product investment business, we can improve the efficiency of capital use, obtain certain investment benefits, and seek more investment returns for the company's shareholders.
(III) Risk Control Analysis
Company strictly follows the approval and implementation procedures of "Entrusted Financial Management System" to ensure the effective development and standardized operation of entrusted financial management and other investment businesses. However, as the financial market is greatly affected by the economic environment, it is not ruled out that investment businesses such as investment and wealth management will be affected by market fluctuations. The company will take the following measures:
( 1 ) The company will clearly assign special personnel to be responsible for the relevant work of such investment matters: the chairman of the company exercises the investment decision-making power and signs relevant contract documents, the company's financial director is responsible for organizing the implementation, and the finance department is responsible for the specific operation.
( 2 ) The company's finance department is responsible for timely analyzing and tracking the investment direction of financial products and the progress of investment projects. If the evaluation finds that there are conditions that may affect the company's capital security or affect the normal capital flow demand, corresponding preservation or redemption measures will be taken in time to control investment risks.
( 3 ) The audit department of the company is responsible for auditing and supervising various investments, and regularly auditing and verifying the progress, profit and loss, and risk control of entrusted financial management. According to the principle of prudence, evaluate the possible risks and benefits of various entrusted financial management and report to the audit committee of the board of directors.
( 4 ) The company fulfills its information disclosure obligations in strict accordance with the relevant regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange.
(IV) Independent Director Opinion
The independent director of the company issued an independent opinion on the resolution, and believed that: the company's entrusted financial management is implemented on the premise of ensuring the company's daily operation and capital safety. It does not affect the company's daily capital turnover and does not affect the normal development of the company's business operations. By carrying out moderate low-risk financial product investment business, we can improve the efficiency of capital use, obtain certain investment benefits, and seek more investment returns for the company's shareholders.# The 174 has not found any damage to the rights and interests of the company and small and medium-sized shareholders. Agree to authorize the chairman to use his own funds for entrusted financial management.
"Announcement on the Progress of Entrusted Financial Management" on 2019 . As of the date of this announcement, the company has recovered all the entrusted financial management due.
As of the date of this announcement, the company's accumulated amount of entrusted financial management is 2.5 .4 billion yuan. See the following table for details:
| Trustee
| Financial Product Type
| Amount
(RMB 10,000)
| Start Date
| Due Date
|
Deadline Announcement Date recovered principal amount (RMB 10,000)
|
income as of the announcement date (RMB 10,000)
|
| 1
| Bank of Communications Jinhua Branch
|
Yuntong Wealth Fixed Term Structured Deposit
|
3,000.00
|
2019/2/1
|
2019/6/6
|
/
|
/
|
| 2
| Guangfa Bank Jinhua Branch
|
Salary Increase 16 RMB structured deposit product
|
5,000.00
|
2019/2/20
|
2019/5/21
|
/
|
/
|
|
Agricultural Bank of China Jinhua Jiangbei Sub-branch
|
Huili Feng 2019 4505 Issue Customized RMB Structured Deposit Product
|
5,000.00
|
2019/2/22
|
2019/5/24
|
/
|
/
|
4
|
Guangfa Bank Jinhua Branch
|
Salary Increase 16 RMB Structured Deposit Product
|
4,000.00
|
2019/4/9
|
2019/7/8
|
/
|
/
|
5
|
Bohai Bank Jinhua Branch
|
Bank Bohai S190534 Structured Deposit Financial Product
|
4,000.00
|
More information
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-30
Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has
2020
07-31
Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute
A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody
2020
07-31
On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.
2020
07-31
Peak natural products pollution control results by the industry attention
As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.
2020
07-31